HUE053131T2 - Kezelési rendszer neurológiai betegség kezelésére - Google Patents
Kezelési rendszer neurológiai betegség kezeléséreInfo
- Publication number
- HUE053131T2 HUE053131T2 HUE10786859A HUE10786859A HUE053131T2 HU E053131 T2 HUE053131 T2 HU E053131T2 HU E10786859 A HUE10786859 A HU E10786859A HU E10786859 A HUE10786859 A HU E10786859A HU E053131 T2 HUE053131 T2 HU E053131T2
- Authority
- HU
- Hungary
- Prior art keywords
- treatment
- neurological disease
- regimes
- treatment regimes
- neurological
- Prior art date
Links
- 208000012902 Nervous system disease Diseases 0.000 title 1
- 208000025966 Neurological disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Management, Administration, Business Operations System, And Electronic Commerce (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18598909P | 2009-06-10 | 2009-06-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE053131T2 true HUE053131T2 (hu) | 2021-06-28 |
Family
ID=43309469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE10786859A HUE053131T2 (hu) | 2009-06-10 | 2010-06-10 | Kezelési rendszer neurológiai betegség kezelésére |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8940699B2 (enExample) |
| EP (2) | EP2440230B1 (enExample) |
| JP (2) | JP6005514B2 (enExample) |
| CN (1) | CN102458441A (enExample) |
| AU (1) | AU2010258664B2 (enExample) |
| BR (1) | BRPI1010718A2 (enExample) |
| CA (1) | CA2765169C (enExample) |
| DK (1) | DK2440230T3 (enExample) |
| ES (1) | ES2847293T3 (enExample) |
| HR (1) | HRP20210112T1 (enExample) |
| HU (1) | HUE053131T2 (enExample) |
| PL (1) | PL2440230T3 (enExample) |
| PT (1) | PT2440230T (enExample) |
| WO (1) | WO2010144721A2 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7510824B2 (en) * | 1999-06-02 | 2009-03-31 | Nono Inc. | Method of screening peptides useful in treating traumatic injury to the brain or spinal cord |
| BRPI1010718A2 (pt) | 2009-06-10 | 2016-03-15 | Nono Inc | sistemas modelo e regimes de tratamento para tratar doença neurológica. |
| EP2616094B1 (en) | 2010-08-12 | 2017-11-08 | NoNO Inc. | Treatment of penetrative injury to the brain |
| KR102022116B1 (ko) | 2011-06-24 | 2019-09-18 | 노노 인코포레이티드 | 허혈에 대한 psd-95 억제제와의 조합 요법 |
| KR102114490B1 (ko) * | 2011-12-13 | 2020-05-25 | 노노 인코포레이티드 | 지주막하 출혈 및 허혈에 대한 치료법 |
| US9241970B2 (en) | 2011-12-13 | 2016-01-26 | Nono Inc. | Therapy for subarachnoid hemorrhage and ischemia |
| AU2013204309A1 (en) * | 2012-11-13 | 2014-05-29 | Biodiem Limited | Therapeutic Compounds and Uses Thereof |
| US10251935B2 (en) | 2012-11-28 | 2019-04-09 | Nono Inc. | Lyophilized formulation comprising tat-NR2B9C, histidine and trehalose |
| HUE043820T2 (hu) * | 2012-11-28 | 2019-09-30 | Nono Inc | Liofilizált TAT-NR2B9c készítmény |
| KR102605540B1 (ko) * | 2014-05-28 | 2023-11-22 | 노노 인코포레이티드 | Tat-nr2b9c의 클로라이드 염 |
| KR20180135493A (ko) * | 2016-04-27 | 2018-12-20 | 바이오셀즈(베이징) 바이오테크 코., 엘티디. | 흥분성 신경독성 관련 손상의 치료 방법 |
| ES2869300T3 (es) * | 2016-04-27 | 2021-10-25 | Biocells Beijing Biotech Co Ltd | Péptido terapéutico para las lesiones relacionadas con la neurotoxicidad excitadora |
| WO2018103038A1 (zh) * | 2016-12-08 | 2018-06-14 | 拜西欧斯（北京）生物技术有限公司 | 一种缀合物及其应用 |
| WO2019006692A1 (zh) * | 2017-07-05 | 2019-01-10 | 拜西欧斯（北京）生物技术有限公司 | 用于治疗、改善或预防神经系统相关病症的化合物及其用途 |
| EA039314B1 (ru) * | 2017-07-05 | 2022-01-12 | Биоселз (Бейдзин) Биотек Ко., Лтд. | Фармацевтически приемлемые соли полипептидов и их применение |
| WO2019061395A1 (zh) | 2017-09-30 | 2019-04-04 | 拜西欧斯（北京）生物技术有限公司 | 兴奋性神经毒性相关损伤的治疗肽组合物 |
| CN113150065B (zh) | 2021-03-11 | 2022-07-08 | 武汉英纳氏药业有限公司 | 一种合成肽及其应用 |
| CN113121641B (zh) | 2021-03-11 | 2022-11-01 | 武汉英纳氏药业有限公司 | 一类多功能多肽及其在医药领域的应用 |
| CN113735938B (zh) | 2021-07-30 | 2024-11-08 | 英纳氏(珠海)药业有限公司 | 一种神经保护多肽化合物及其应用 |
| CN114642402A (zh) * | 2022-03-07 | 2022-06-21 | 翰博瑞强(上海)医药科技有限公司 | 一种用于预测药物对心脏毒性影响的方法及心电图设备 |
| CN114469084B (zh) * | 2022-04-02 | 2022-06-24 | 剑博微电子(深圳)有限公司 | 一种基于高精度adc的血氧监测系统 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060148711A1 (en) | 1999-05-14 | 2006-07-06 | Arbor Vita Corporation | Molecular interactions in neurons |
| US7510824B2 (en) * | 1999-06-02 | 2009-03-31 | Nono Inc. | Method of screening peptides useful in treating traumatic injury to the brain or spinal cord |
| GB0025473D0 (en) | 2000-10-17 | 2000-11-29 | Pfizer Ltd | Pharmaceutical combinations |
| WO2004045535A2 (en) * | 2002-11-14 | 2004-06-03 | Arbor Vita Corporation | Molecular interactions in neurons |
| US20060276455A1 (en) | 2003-02-13 | 2006-12-07 | Lindsberg Perttu J | Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of cerebral ischemia |
| PL1622639T3 (pl) | 2003-05-02 | 2013-06-28 | Lundbeck H As | Dożylne wstrzyknięcie nieneurotoksycznych aktywatorów plazminogenu do leczenia udaru mózgu |
| ES2804424T3 (es) * | 2006-07-11 | 2021-02-08 | Nono Inc | Péptido y composición del mismo para usar en el tratamiento del accidente cerebrovascular con fiebre |
| EP1884521A1 (en) * | 2006-07-31 | 2008-02-06 | Xigen S.A. | Fusion peptide for inhibiting interaction of neuronal NMDA receptor (NMDAR) and NMDAR interacting proteins |
| EP2120987B1 (en) * | 2007-03-02 | 2014-01-15 | NoNO Inc. | Treating stroke and other diseases without inhibiting n-type calcium channels |
| WO2009006611A1 (en) | 2007-07-03 | 2009-01-08 | Arbor Vita Corporation | Small molecule inhibitors of pdz interactions |
| US8080518B2 (en) | 2007-12-05 | 2011-12-20 | Arbor Vita Corporation | Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| PL2320927T3 (pl) | 2008-07-09 | 2016-02-29 | Univ Copenhagen | Modyfikowane peptydy jako potencjalne inhibitory w reakcjach receptorów PSD 95 i NMD |
| BRPI1010718A2 (pt) | 2009-06-10 | 2016-03-15 | Nono Inc | sistemas modelo e regimes de tratamento para tratar doença neurológica. |
| KR102022116B1 (ko) | 2011-06-24 | 2019-09-18 | 노노 인코포레이티드 | 허혈에 대한 psd-95 억제제와의 조합 요법 |
| KR102114490B1 (ko) | 2011-12-13 | 2020-05-25 | 노노 인코포레이티드 | 지주막하 출혈 및 허혈에 대한 치료법 |
| US9241970B2 (en) | 2011-12-13 | 2016-01-26 | Nono Inc. | Therapy for subarachnoid hemorrhage and ischemia |
-
2010
- 2010-06-10 BR BRPI1010718A patent/BRPI1010718A2/pt not_active Application Discontinuation
- 2010-06-10 HU HUE10786859A patent/HUE053131T2/hu unknown
- 2010-06-10 ES ES10786859T patent/ES2847293T3/es active Active
- 2010-06-10 US US13/377,523 patent/US8940699B2/en active Active
- 2010-06-10 CA CA2765169A patent/CA2765169C/en active Active
- 2010-06-10 JP JP2012515147A patent/JP6005514B2/ja not_active Expired - Fee Related
- 2010-06-10 EP EP10786859.8A patent/EP2440230B1/en active Active
- 2010-06-10 PL PL10786859T patent/PL2440230T3/pl unknown
- 2010-06-10 CN CN2010800352462A patent/CN102458441A/zh active Pending
- 2010-06-10 DK DK10786859.8T patent/DK2440230T3/da active
- 2010-06-10 HR HRP20210112TT patent/HRP20210112T1/hr unknown
- 2010-06-10 AU AU2010258664A patent/AU2010258664B2/en not_active Ceased
- 2010-06-10 EP EP20200385.1A patent/EP3808366A1/en not_active Withdrawn
- 2010-06-10 PT PT107868598T patent/PT2440230T/pt unknown
- 2010-06-10 WO PCT/US2010/038200 patent/WO2010144721A2/en not_active Ceased
-
2015
- 2015-01-14 US US14/597,166 patent/US9610323B2/en not_active Expired - Fee Related
- 2015-10-30 JP JP2015214926A patent/JP6220371B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US8940699B2 (en) | 2015-01-27 |
| AU2010258664A1 (en) | 2012-01-12 |
| CA2765169A1 (en) | 2010-12-16 |
| EP2440230B1 (en) | 2020-11-11 |
| AU2010258664B2 (en) | 2015-05-28 |
| US20120269733A1 (en) | 2012-10-25 |
| WO2010144721A3 (en) | 2011-04-21 |
| JP2012530057A (ja) | 2012-11-29 |
| JP6220371B2 (ja) | 2017-10-25 |
| ES2847293T3 (es) | 2021-08-02 |
| BRPI1010718A2 (pt) | 2016-03-15 |
| JP6005514B2 (ja) | 2016-10-12 |
| DK2440230T3 (da) | 2021-01-18 |
| PT2440230T (pt) | 2021-02-03 |
| EP2440230A2 (en) | 2012-04-18 |
| HRP20210112T1 (hr) | 2021-04-16 |
| CA2765169C (en) | 2019-06-18 |
| US20150202253A1 (en) | 2015-07-23 |
| US9610323B2 (en) | 2017-04-04 |
| CN102458441A (zh) | 2012-05-16 |
| JP2016041731A (ja) | 2016-03-31 |
| WO2010144721A2 (en) | 2010-12-16 |
| EP3808366A1 (en) | 2021-04-21 |
| PL2440230T3 (pl) | 2021-06-14 |
| EP2440230A4 (en) | 2014-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE053131T2 (hu) | Kezelési rendszer neurológiai betegség kezelésére | |
| IL217777A0 (en) | Methods for treatment of pain | |
| IL217901A0 (en) | Treatment of bdnf-related disorders using laquninimod | |
| IL219073A (en) | A drug combination for cancer treatment | |
| IL211857A (en) | Neurological Treatment System | |
| IL215767A0 (en) | Methods of treatment for solid tumors | |
| EP2409634A4 (en) | ENDOSCOPE OF TREATMENT | |
| GB0908193D0 (en) | Treatment of disease state | |
| ZA201109278B (en) | Method for treatment of diseases | |
| GB0906159D0 (en) | Drug combination for the treatment of proteostatic diseases | |
| PL2477656T3 (pl) | Leczenie stanów neurologicznych | |
| GB0914839D0 (en) | Treatment of oil | |
| ZA201202379B (en) | Antagonists of dsgs2 for treatment of cancer | |
| GB0908666D0 (en) | Treatment of proteostatic disease | |
| GB0819543D0 (en) | Treatment of proteostatic disease | |
| GB0817859D0 (en) | Treatment of proteostatic disease | |
| HU0900722D0 (en) | Compounds for the treatment of neurological disorders | |
| TWM390783U (en) | Improved structure of push bed for medical treatment | |
| HU0900504D0 (en) | Cream for treatment of skin-irritation | |
| GB0913427D0 (en) | Compounds for treatment of imflammation | |
| HK1173678A (en) | Treatment of neurological conditions | |
| GB0911418D0 (en) | Treatment of degenerative disc disease | |
| GB0906179D0 (en) | Treatment of proteostatic desease |